Sanofi and GSK to seek authorization for COVID vaccine

$ 20.99 · 5 (478) · In stock

Recon: Sanofi, GSK to seek approval for COVID vaccine candidate; Novavax begins shipping vaccines to EU states

Sanofi-GSK COVID-19 Booster More Protective Against Omicron Than Pfizer-BioNTech

EMA starts review of Sanofi-GSK COVID vaccine application

A closer look at the vaccines Canada is betting on to stem the spread of COVID-19

New vaccine demonstrates 100% efficacy against severe COVID, hospitalizations - CBS New York

Special report on EU COVID-19 vaccine procurement

COVID vaccine from Sanofi and GSK is delayed, triggering uncertainty ahead of Europe's mass inoculation campaigns - MarketWatch

Sanofi-GSK Covid-19 vaccine triggers immune responses in trial

Sanofi, GSK post 58% efficacy in omicron-affected COVID-19 vaccine trial, teeing up race to regulators

Sanofi and GSK plan to ask regulators to authorize their COVID-19 vaccine - ABC News